Latest filing published 16 Nov 2017 for Medite Cancer Diagnostics, Inc., €149k.
No signal scores available.
This profile gathers the share dealings of Susan Weisman across 2 companies, led by Coach Industries Group Inc and Medite Cancer Diagnostics, Inc. In total, 3 filings cover trades dated from 15 February 2006 to 26 April 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 16 November 2017 came the latest disclosure, a share grant for €149k in Medite Cancer Diagnostics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 36 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations